CRO Intel
Dashboard
Companies
Opportunity Signals
Clinical Trials
Hiring Intelligence
Funding
Publications
FDA
Settings
Company Intelligence
Discover companies with clinical, regulatory and hiring signals
Sync Companies
All States
California
Texas
Massachusetts
All Types
Biotech
Pharma
CRO
Total Companies
6,643
Company
Clinical Trials
FDA Signals
Hiring
Opportunity
Confidence
Last Seen
Abx-cro Advanced Pharmaceutical Services Forschungsgesellschaft Mbh
—
—
—
60
36%
7/17/2026
View Intelligence
Acacia Pharma
—
—
—
60
36%
7/17/2026
View Intelligence
Acadia Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Acanthas Pharma
—
—
—
60
36%
7/17/2026
View Intelligence
Acceleron Pharma A Wholly-owned Subsidiary Of Merck & Rahway Nj Usa
1
trials
—
—
60
36%
7/17/2026
View Intelligence
Accent Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Accentia Biopharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Access Business Group
—
—
—
60
42%
7/20/2026
View Intelligence
Access Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Accession Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Accord Healthcare
—
—
—
60
41%
7/20/2026
View Intelligence
Accsalus Biosciences
—
—
—
60
36%
7/17/2026
View Intelligence
Accudial Pharmaceutical
—
—
—
60
36%
7/17/2026
View Intelligence
Accure Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Accuredit Therapeutics Us
—
—
—
60
36%
7/17/2026
View Intelligence
Accutarget Medipharma (shanghai)
—
—
—
60
36%
7/17/2026
View Intelligence
Ace Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Acea Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Acelink Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Acella Pharmaceuticals
—
—
—
60
42%
7/20/2026
View Intelligence
Acellytron Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Acer Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Acerand Therapeutics (hong Kong)
—
—
—
60
36%
7/17/2026
View Intelligence
Acerand Therapeutics (shanghai)
—
—
—
60
36%
7/17/2026
View Intelligence
Acerta Pharma
—
—
—
60
36%
7/17/2026
View Intelligence
Acerus Biopharma
—
—
—
60
36%
7/17/2026
View Intelligence
Acerus Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Acesion Pharma
—
—
—
60
36%
7/17/2026
View Intelligence
Acetylon Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Achaogen
—
—
—
60
40%
7/20/2026
View Intelligence
Achelios Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Achilles Therapeutics Uk
—
—
—
60
36%
7/17/2026
View Intelligence
Aci Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Aciex Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Aclaris Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Acme United
—
—
—
60
42%
7/20/2026
View Intelligence
Acne Free
—
—
—
60
42%
7/20/2026
View Intelligence
Acorda Therapeutics
1
trials
—
—
60
36%
7/17/2026
View Intelligence
Acousia Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Acrivon Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Acrotech Biopharma
1
trials
—
—
60
36%
7/17/2026
View Intelligence
Acta Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Actavis Pharma
—
—
—
60
42%
7/20/2026
View Intelligence
Actelion Pharmaceuticals Deutschland
2
trials
—
—
60
36%
7/17/2026
View Intelligence
Actimed Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Actinium Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Actio Biosciences
1
trials
—
—
60
36%
7/17/2026
View Intelligence
Action Pharma A/s
—
—
—
60
36%
7/17/2026
View Intelligence
Activbiotics Pharma
—
—
—
60
36%
7/17/2026
View Intelligence
Activx Biosciences
—
—
—
60
36%
7/17/2026
View Intelligence
Showing
101
-
150
of
6,643
companies
Previous
1
2
3
4
5
Next